Biomarkers in the era of personalized medicine - A multiplexed SNP assay using capillary electrophoresis for assessing drug metabolism capacity

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue SUPPL. 242, 2010, Pages 15-18

  Rai, Alex J ^a,b   Yee, Jessica ^b   Fleisher, Martin ^b  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cytochrome P450; Pharmacogenetics; Single base extension; Single nucleotide polymorphisms (SNPs)

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME P450 2D6; GENOMIC DNA; OLIGONUCLEOTIDE; PHARMACOLOGICAL BIOMARKER;

ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; DIAGNOSTIC ACCURACY; DNA EXTRACTION; DNA SEQUENCE; EXTENSION GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE TARGETING; GENOTYPE; HUMAN; METABOLIC REGULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; FEASIBILITY STUDY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC SCREENING; GENETICS; INSTRUMENTATION; METHODOLOGY; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHARMACOKINETICS;

BIOMARKERS, PHARMACOLOGICAL; CYTOCHROME P-450 CYP2D6; ELECTROPHORESIS, CAPILLARY; FEASIBILITY STUDIES; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC TESTING; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS; PHARMACOKINETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953155774     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2010.493355     Document Type: Article

References (8)

1. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med. 2003 Feb. 6; 348 (6):538-49.
2. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004;429(6990):464-8.
3. Ely S. Personalized medicine: individualized care of cancer patients. Transl Res. 2009;154(6):303-8. Epub 2009 Sep. 1.
4. Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41(2):89-295.
5. Owen RP, Sangkuhl K, Klein TE, Altman RB. Cytochrome P450 2D6. Pharmacogenet Genomics. 2009 Jul; 19 (7):559-62.
6. http://www.cypalleles.ki.se/cyp2d6.htm (Accessed 100510).
7. Roberts RL, Kennedy MA. Rapid detection of common cytochrome P450 2D6 alleles in Caucasians. Clin Chim Acta. 2006;366(1-2): 348-51. Epub 2005 Dec. 20.
8. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001;286(18):2270-9.